MedPath

Feasibility of sentinel lymph node biopsy for acquired clinical node-negative breast cancer after neoadjuvant therapy in node-positive breast cancer, multi-centric, single arm, phase II, confirmatory study

Phase 2
Conditions
Breast cancer
Registration Number
JPRN-UMIN000030510
Lead Sponsor
Osaka City General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Female
Target Recruitment
19
Inclusion Criteria

Not provided

Exclusion Criteria

Inoperable case Inflammatory breast cancer Progressive disease after neoadjuvant therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3-year axillary lymph node relapse free survival
Secondary Outcome Measures
NameTimeMethod
Diagnostic potential of SNB 3-year disease-free and overall survival Relation between relapse site and clinicopathological factor Rate of arm lymphedema
© Copyright 2025. All Rights Reserved by MedPath